Theravance Biopharma Balance Sheet (2013-2025) | TBPH

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	114.01M	204.95M	121.42M	89.96M	94.37M	87.29M	418.54M	298.17M	187.66M	105.60M	71.69M	39.55M	53.84M	46.34M	23.38M	37.80M	110.61M	281.93M	174.77M	167.81M
Short-term Investments (Quarter)	95.96M	60.00M	94.79M	83.51M	53.15M	45.56M	68.29M	29.31M	53.60M	61.85M	62.32M	62.88M	46.14M	49.73M	67.98M	50.55M	20.24M	56.88M	2.39M	147.55M
Cash & Current Investments (Quarter)	209.97M	264.95M	216.21M	173.47M	147.52M	132.85M	486.83M	327.48M	241.26M	167.45M	134.00M	102.43M	99.97M	96.08M	91.36M	88.35M	130.85M	338.80M	177.16M	315.36M
Receivables - Net (Quarter)
Receivables - Other (Quarter)	42.36M	12.22M	43.77M	42.49M	12.28M	12.49M	14.11M	16.79M	12.27M	15.80M	17.06M	17.47M	14.66M	14.30M	16.84M	18.44M	15.35M	21.92M	18.27M	45.54M
Receivables (Quarter)
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)
Prepaid Assets (Quarter)	10.04M	12.35M	9.94M	8.56M	4.54M	7.08M	8.13M	7.68M	6.28M	7.78M	9.00M	11.60M	7.57M	6.28M	7.68M	4.28M	4.06M	5.57M	6.75M	7.56M
Current Assets (Quarter)	293.07M	333.18M	297.17M	249.87M	204.64M	154.73M	511.72M	353.46M	261.34M	192.00M	161.69M	133.54M	124.29M	119.31M	116.48M	161.07M	150.26M	366.29M	354.70M	418.46M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	16.94M	16.58M	16.00M	13.66M	13.24M	12.53M	11.88M	11.88M	12.10M	9.55M	9.29M	9.07M	8.72M	8.14M	7.79M	7.42M	7.03M	6.64M	6.26M	5.89M
Long-Term Investments (Quarter)	19.44M	35.82M	45.09M	67.54M	94.11M	148.25M			18.78M							2.29M	2.33M	2.37M	3.03M	11.13M
Long-Term Deferred Tax (Quarter)								440.75M				447.30M				2.43M
Other Non-Current Assets (Quarter)	0.83M	1.32M	0.83M	0.84M	3.19M	0.84M	4.87M	6.90M	0.84M	0.84M	0.84M	0.84M	7.90M	7.73M	0.84M	0.84M	0.84M	0.84M	25.19M	0.84M
Non-Current Assets (Quarter)	82.04M	96.07M	105.94M	37.70M	150.72M	206.03M	251.78M	253.94M	277.21M	254.63M	251.90M	248.46M	247.01M	242.72M	239.62M	193.09M	193.32M	59.74M	60.76M	67.11M
Assets (Quarter)	375.11M	429.25M	403.11M	374.82M	355.36M	360.76M	763.50M	607.40M	538.55M	446.63M	413.59M	382.00M	371.31M	362.03M	356.11M	354.16M	343.58M	426.04M	415.46M	485.57M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	6.83M	10.70M	8.90M	3.10M	1.51M	3.07M	5.34M	1.55M	2.66M	1.57M	2.37M	1.52M	1.69M	1.67M	1.45M	2.24M	2.41M	1.68M	2.21M	2.57M
Payables (Quarter)	6.83M	10.70M	8.90M	3.10M	1.51M	3.07M	5.34M	1.55M	2.66M	1.57M	2.37M	1.52M	1.69M	1.67M	1.45M	2.24M	2.41M	1.68M	2.21M	2.57M
Accumulated Expenses (Quarter)	15.62M	14.63M	8.63M	1.25M	5.84M	3.99M	7.56M	10.31M	5.03M	5.37M	6.58M	6.44M	4.47M	5.77M	7.84M	7.02M	5.39M	7.26M	10.33M	12.59M
Other Accumulated Expenses (Quarter)	1.83M	1.50M	1.83M	1.30M	0.79M	2.27M	0.14M	1.14M	1.43M	1.54M	1.51M	1.24M	1.07M	0.86M	1.21M	2.21M	2.07M	1.86M	1.33M	1.49M
Short term Debt (Quarter)	11.66M	6.94M	12.53M	16.94M	9.01M
Current Leases (Quarter)	1.22M	1.04M	1.02M	0.50M	4.05M	2.62M	0.69M	6.75M	7.43M	9.16M	9.71M	3.92M	4.06M	4.22M	4.20M	10.71M	10.81M	10.90M	10.91M	10.95M
Current Taxes (Quarter)																5.85M	5.85M	26.70M	4.07M	5.29M
Current Deferred Revenue (Quarter)	7.66M	5.69M	2.90M	0.10M	0.10M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M
Total Current Liabilities (Quarter)	86.49M	67.13M	66.08M	58.59M	44.20M	32.62M	142.13M	28.71M	26.18M	24.55M	25.37M	24.77M	21.66M	22.95M	23.43M	32.09M	31.50M	54.63M	37.41M	38.30M
Non-Current Liabilities
Non-Current Debt (Quarter)	375.18M	375.07M	375.57M	371.36M	384.16M	396.12M
Convertible Debt (Quarter)	227.23M	227.50M	227.77M	228.03M	228.30M	228.57M
Non-Current Deffered Revenue (Quarter)	0.34M	0.33M	0.32M	0.31M	0.30M	0.20M	0.20M	0.19M	0.19M	0.18M	0.17M
Operating Leases (Quarter)	57.03M	57.77M	54.35M	52.68M	47.41M	50.64M	51.38M	45.41M	43.76M	42.52M	41.12M	45.24M	43.84M	42.44M	40.78M	39.11M	37.35M	35.56M	33.68M	31.76M
Other Non-Current Liabilities (Quarter)	2.06M	1.83M	2.61M	75.02M	2.43M	2.40M	1.66M	76.00M	7.68M	7.68M	7.68M	79.47M	5.45M	4.88M	4.98M	83.70M	1.29M	1.55M	0.31M	88.80M
Total Non-Current Liabilities (Quarter)	746.27M	727.79M	724.09M	638.37M	704.38M	708.17M	281.26M	89.60M	160.31M	158.79M	159.78M	89.53M	160.99M	163.46M	165.47M	94.92M	176.31M	199.64M	182.47M	100.05M
Total Liabilities (Quarter)	748.33M	729.62M	726.70M	713.39M	706.81M	710.57M	282.92M	165.60M	167.99M	166.47M	167.46M	169.00M	166.44M	168.34M	170.45M	178.62M	177.60M	201.19M	182.78M	188.85M
Shareholder's Equity
Total Debt (Quarter)	386.84M	382.01M	388.10M	388.30M	393.17M	396.12M
Common Equity (Quarter)	-373.22M	-300.37M	-323.59M	-338.57M	-351.45M	-349.81M	480.58M	441.80M	370.56M	280.16M	246.13M	213.00M	204.87M	193.69M	185.65M	175.54M	165.98M	224.85M	232.68M	296.72M
Shareholder's Equity (Quarter)	-373.22M	-300.37M	-323.59M	-338.57M	-351.45M	-349.81M	480.58M	441.80M	370.56M	280.16M	246.13M	213.00M	204.87M	193.69M	185.65M	175.54M	165.98M	224.85M	232.68M	296.72M
Liabilities and Shareholders Equity (Quarter)	375.11M	429.25M	403.11M	374.82M	355.36M	360.76M	763.50M	607.40M	538.55M	446.63M	413.59M	382.00M	371.31M	362.03M	356.11M	354.16M	343.58M	426.04M	415.46M	485.57M
Retained Earnings (Quarter)	-1606.30M	0.01M	0.01M	-1726.04M	-0.03M	-0.04M	-843.55M	-0.01M	0.05M	-0.29M	-900.59M	-0.07M	-920.77M	-937.30M	-950.00M	0.01M	-979.10M	-0.01M	0.03M	-859.63M
Treasury Shares (Quarter)				8.35M			9.64M	4.11M	5.16M	7.28M	15.62M	4.00M	3.07M	4.53M	4.28M	3.96M	4.48M	4.10M	3.74M	3.20M

Research Tools

Theravance Biopharma Balance Sheet (2013-2025) | TBPH

Create an account

Sign In

Reset Password